top of page
Semler-Scientific_Registered_New Green.png

A Trusted Solution to Support
Early Detection of PAD

PAD.png

Reliable, Rapid and Accessible

QuantaFlo® can be performed at the point of care in less than 3-minutes, eliminating the need for complex equipment and highly trained personnel. This makes it easier for healthcare providers to incorporate PAD testing into their routine practices.

Learn More About QuantaFlo for Early PAD Detection

Discover how QuantaFlo can enhance your practice with quick, accurate PAD screening at the point of care. See how this easy-to-use tool supports early intervention and better patient outcomes.

A Patient's Guide to Early
Detection with QuantaFlo

PAD ABI.jpeg

Why Early Detection Matters?

Detecting PAD early allows your healthcare team to discuss preventive steps and treatments that may help reduce your risks for complications. QuantaFlo offers accurate, quick results, providing you and your provider with the information needed to take proactive steps for better vascular health

Take the First Steps in Protecting Your Health

Are you at risk for Peripheral Arterial Disease (PAD)? Answer a few quick questions to assess your risk factors. Completing this brief questionnaire will help you understand whether PAD testing might benefit you.

ML00213.A2_MedAxiom-Webinar-1024x576.png

In this webinar, expert speakers discuss the importance of early detection of peripheral artery disease (PAD) in optimizing goal-directed medical treatment. Risk factor management and targeted appropriate interventions prevent disease progression and improve outcomes. Through a review of case examples, speakers illustrate the positive impact of volume plethysmography-based PAD detection at the point of care and multidisciplinary coordinated care on patient outcomes.
 

Please fill out the form to access the full webinar.

Challenges in Managing Peripheral
Arterial Disease

AdobeStock_441350953.jpeg

Managing Peripheral Artery Disease (PAD) poses several significant challenges for healthcare providers and patients alike. Understanding these challenges is crucial for improving detection, treatment, and patient outcomes.

Watch the video below to hear Dr. Sonya Tuerff discuss the challenges of managing PAD.

Limited Appointment Time

Healthcare providers often face constraints in their schedules, leading to limited time for comprehensive physical examinations and thorough history-taking. This can result in missed opportunities for early detection, especially with asymptomatic patient population or even those presenting with atypical symptoms.

Scheduling delays for any follow up may further impact timely follow up treatment plans.

Coverage for PAD Testing

PAD may not be covered by insurance, particularly for asymptomatic patients. This lack of reimbursement discourages both patients and providers from pursuing early diagnostic tests and preventive treatments.

Educational Gaps

There is a notable lack of education regarding PAD, particularly concerning early detection and holistic treatment approaches. Both patients and clinicians often lack awareness of the disease’s risks, symptoms, and management strategies, which can lead to delayed diagnosis and treatment.

Specialist Focus

Specialists often prioritize interventions or focus on their subspecialties, such as coronary artery disease. This can create a fragmented approach to care, where PAD may not receive the attention it requires in a broader cardiovascular context.

Managing Peripheral Arterial Disease (PAD) is challenging due to its often asymptomatic nature, the need for early detection in high-risk populations, and the necessity of comprehensive care that addresses both lifestyle modifications and medical interventions.

Disparities in PAD: A Growing Concern

AdobeStock_441350953.jpeg

The “Silent Killer” ~30% of Americans Don’t Know They Have.

PAD - The "Silent Killer"

AdobeStock_218340546 (1).jpeg

Peripheral Arterial Disease (PAD) significantly increases the risk of heart attack and stroke. often going undetected because it progresses with minimal symptoms, earning it the label of a "silent killer."

The Impact and Progression of Peripheral Arterial Disease

Patient and Provider.jpg
PAD.png
Learn more about how QuantaFlo can improve outcome for your PAD patients.
bottom of page